Expertise

We read what Rx data
structurally cannot.

Reach clinicians. Understand behaviour. Activate the right audiences. One intelligence system built to improve launch, adoption and growth.

Scroll

The compounding system

Three tiers. One Intelligence Loop.

Each interaction generates behavioural signal. Behavioural signal becomes intelligence. Intelligence improves activation. Activation generates new signal.

Each tier feeds the next. Activation refines intelligence, intelligence sharpens visibility. The loop compounds with time.

Tier 01

Visibility & Reach

Reach HCPs where they already go for clinical science. We establish a foundational presence within trusted digital ecosystems, securing share of voice and initiating the engagement loop.

What clinicians see.

Tier 02

Behavioral Intelligence

Turn engagement into strategic intelligence. We decode behavioral signals, mapping complex digital footprints to understand intent, preferences, and knowledge gaps.

What clinicians actually seek, trust and learn from.

Tier 03

HCP Activation

Activate warm, consented HCP audiences. We identify high-value behavioral cohorts and deploy hyper-targeted interventions that drive measurable clinical outcomes.

How behaviour becomes action.

One intelligence loop. Built for launch, growth and strategic decisions.

What GNM does

Four dimensions of the behavioural layer.

  1. What evidence are clinicians seeking right now?

    Understand what clinicians actively seek, explore and engage with, before changes in prescribing behaviour become visible.

    Evidence demand
  2. Who are the real scientific leaders in each specialty?

    Identify the clinicians who shape scientific discussion, accelerate knowledge exchange and drive peer engagement within their communities.

    Evidence mapping
  3. Where are the scientific readiness gaps by region?

    Reveal differences in awareness, understanding and therapeutic readiness across geographies, institutions and physician segments.

    Adoption readiness
  4. What do physicians trust enough to act on?

    Measure how confidence in evidence develops across clinical communities and understand what drives behavioural change.

    Trust & conviction

Conviction Intelligence Flywheel

Every interaction strengthens the intelligence behind better decisions.

    • Trusted source of weekly clinical intelligence
    • Engagement across global specialist communities
    • 12 vaccine indications covered
    • 2 regions · France · LATAM
    • 15 travel diseases covered
    • 10 countries · Europe · USA
    • Valves · Pacemakers · Stents covered
    • 12 countries · Europe
    • Transthyretin amyloidosis ecosystem
    • 6 countries · Europe
    • Von Willebrand disease ecosystem
    • 9 countries · Global

Unlike traditional market data, which reports outcomes after they happen, Conviction Intelligence is continuously enriched through real-world clinician engagement.

Next step

Start with visibility. Add intelligence. Unlock activation.

Talk to an expert

Discuss your market, launch or therapeutic area with a GNM intelligence specialist.